Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

JoF Statistics

Overview

Journal of Fungi in Numbers

Journal of Fungi (ISSN: 2309-608X)

Founded: 2015 (Volumes: 8)

2,509 articles published so far

395 articles have been cited 10 times or more

H5-Index: 43 (Mycology)

Impact Factor

Current Impact Factor: 5.816

5-year Impact Factor: 6.499

JCR category rank: Q1: Mycology | Q1: Microbiology


Impact Factor

Citable Items & Citations

JoF Access Trend

Top 10 Cited Papers

Citations Article
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
Global Epidemiology of Mucormycosis
Innate and Adaptive Immune Defects in Chronic Pulmonary Aspergillosis
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
FungiDB: An Integrated Bioinformatic Resource for Fungi and Oomycetes
Epidemiology and Diagnosis of Mucormycosis: An Update
New Trends in Paracoccidioidomycosis Epidemiology
Candida Species Biofilms’ Antifungal Resistance
Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens
Citations Article
COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Epidemiology and Diagnosis of Mucormycosis: An Update
 
Oral Candidiasis: A Disease of Opportunity
 
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
 
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
 
Vulvovaginal Candidiasis: A Current Understanding and Burning Questions
 
Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
 
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
 
Bloodstream Infection by Saccharomyces cerevisiae in Two COVID-19 Patients after Receiving Supplementation of Saccharomyces in the ICU

JoF Statistics from Scopus

CiteScore: 4.1
view Scopus page
SJR data, view statistics from SCImago

JoF Statistics

Rejection Rates by Year

Publication Time



Back to TopTop